The global life sciences industry is witnessing a shift towards improved patient safety through proactive identification of risks and increased focus on safety regulations. Ineffective practices in Pharmacovigilance can lead to higher regulatory penalties owing to non-compliance, including delays in authorization for product registration and marketing.
As a leader in pharmacovigilance and drug safety, Unicon Sciences provides services to companies of all sizes. Our commitment to drug safety allows your company to ensure timely submission of quality adverse event data to various regulatory authorities across the globe.Our pharmacovigilance team is the best in the business. Our team of experts specializes in end-to-end safety surveillance activities for both investigational and post-marketed products.
Get in touch today to learn more about drug safety and how we can help protect your company.
